Press release
Growing Demand for Viscosupplementation Driven by Rising Osteoarthritis Cases and Technological Advancements
Viscosupplementation Market
The Global Impact of Osteoarthritis
Osteoarthritis (OA) is a widespread condition, impacting approximately 3.3% to 3.6% of the global population, as reported by the National Institutes of Health (NIH). This debilitating disease affects around 43 million people, causing moderate to severe disability. In the United States alone, over 32.5 million individuals are estimated to have OA, with the risk rising significantly in the geriatric population; about 80% of those over 65 show signs of the condition. Additionally, countries like India and China report high prevalence rates, with estimates indicating that between 22% and 39% of Indians are afflicted with osteoarthritis.
Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.emergenresearch.com/request-sample/2773
Key Drivers of the Viscosupplementation Market
Sports-Related Injuries: The increasing incidence of sports injuries is a notable factor driving the demand for viscosupplementation. The NIH reports an average injury rate of 2.6 per 1,000 hours in sports, with soccer leading in injuries at a rate of 7.21. Common injuries include ankle injuries (36.12%), knee injuries (19.32%), and shoulder injuries (6.47%). In response, numerous orthopedic companies are now offering viscosupplementation as a solution for joint pain resulting from these injuries.
Investment and Innovation: The viscosupplementation market is witnessing increased investments and advancements in research and development. New formulations of hyaluronic acid treatments are being introduced to enhance effectiveness. For example, BioSenic recently announced its improved viscosupplement for knee osteoarthritis, which combines pain relief and anti-inflammatory properties.
Technological Advancements: New delivery systems, such as microspheres, nanoparticles, and hydrogels, are being developed to enhance the bioavailability of viscosupplements. Intra-articular injections remain the most common method for delivering hyaluronic acid, aimed at improving pain management and joint lubrication.
Hydrogel Innovations: Recent innovations in hydrogel technology have led to the launch of new products designed for intra-articular drug delivery. Contura International Ltd recently unveiled a novel hydrogel injection for knee osteoarthritis, designed to offer an effective, safe, and minimally invasive treatment option.
Challenges Facing the Viscosupplementation Market
Despite the promising growth, the viscosupplementation market faces challenges. The high cost of hyaluronic acid and the availability of alternative treatments may hinder market expansion. Additionally, common side effects associated with the treatment, such as joint pain and swelling, along with rare risks like infections, could deter some patients.
Market Segment Insights
The viscosupplementation market can be categorized by dosage type and application:
Dosage Type: The single injection segment dominated the market in 2022, largely due to its ease of application and comfort for patients. Companies like Seikagaku Corporation have launched single-injection products that simplify treatment. The three-injection segment is also growing, favored for its lower cost and effectiveness in preventing more severe interventions like total knee replacement.
Application: The knee osteoarthritis segment is anticipated to hold a substantial market share, driven by the rising number of cases among the aging population. Strategic initiatives by market players, such as Synartro AB's introduction of a novel therapeutic compound for knee osteoarthritis, are likely to contribute to growth. The hip osteoarthritis segment is also poised for steady growth, largely due to rising obesity rates and related conditions.
Requesting A Customised Report @https://www.emergenresearch.com/request-for-customization/2773
Viscosupplementation Top Companies and Competitive Landscape
The global viscosupplementation market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective viscosupplementation solutions in the market.
Some major players included in the global viscosupplementation market report are:
Sanofi
Hoffmann-La Roche Ltd.
Anika Therapeutics, Inc.
Zimmer Biomet.
Bioventus
Fidia Farmaceutici S.p.A.
SEIKAGAKU CORPORATION
Chugai Pharmaceutical Co., Ltd.
OrthogenRx, Inc.
Miravo Healthcare
APTISSEN
LG Chem
AVNS
Smith+Nephew
Lifecore Biomedical, Inc.
Medical Device Business Services, Inc.
Wellchem Pharmaceuticals Pte Ltd.
Teva Pharmaceutical Industries Ltd.
Labrha International
Ferring B.V.
Viscosupplementation Latest Industry Updates
On 17 September 2023, KiOmed Pharma and Arsylab, a French biotechnology company specializing in the design and marketing of innovative products to improve patients' quality of life, announced the strategic collaboration to enter the French market for promotion and distribution of KioMedineone, a new class of knee osteoarthritis treatment.
On 19 September 2022, Alkem Laboratories announced the regulatory approval of federal agency the Drug Controller General of India (DCGI) for the launch of StemOne, designated for treatment of Knee Osteoarthritis (OA) in collaboration with Stempeutics in India.
To Read More About The Report, Visit @https://www.emergenresearch.com/industry-report/viscosupplementation-market
Viscosupplementation Market Segmentation Analysis
For the purpose of this report, Emergen Research has segmented the global viscosupplementation market on the basis of dosage type, application, source, end-use, and region:
Dosage Type Outlook (Revenue, USD Billion; 2019-2032)
Single Injection
Three Injection
Five Injection
Application Outlook (Revenue, USD Billion; 2019-2032)
Knee Osteoarthritis
Hip Osteoarthritis
Hand/ Wrist Osteoarthritis
Ankle/ Foot Osteoarthritis
Shoulder Osteoarthritis
Others
Source Outlook (Revenue, USD Billion; 2019-2032)
Animal
Non-animal
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers (ASCs)
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
To Purchase Now, Click Here @https://www.emergenresearch.com/select-license/2773
Enhancing Knowledge: A Guide to Related Industry Reports
Viscosupplementation Market Size @ https://www.emergenresearch.com/industry-report/viscosupplementation-market/market-size
Viscosupplementation Market Share @ https://www.emergenresearch.com/industry-report/viscosupplementation-market/market-share
Viscosupplementation Market Trends @ https://www.emergenresearch.com/industry-report/viscosupplementation-market/market-trends
Viscosupplementation Regional Market Demand @ https://www.emergenresearch.com/industry-report/viscosupplementation-market/regional-market-demand
Viscosupplementation Market Analysis @ https://www.emergenresearch.com/industry-report/viscosupplementation-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growing Demand for Viscosupplementation Driven by Rising Osteoarthritis Cases and Technological Advancements here
News-ID: 3684852 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical…
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost…
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in…
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation…
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
